Raccomandazione analisti SpringWorks Therapeutics, Inc.

Azioni

Tempo reale stimato Cboe BZX Altri mercati azionari 20:00:56 01/05/2024			Variaz. 5gg	Var. 1 gen.
45,86 ^USD	-1,78%		+6,86%	+27,00%

12/03	Transcript : SpringWorks Therapeutics, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-12-2024 09:00 AM
07/03	SPRINGWORKS THERAPEUTICS, INC. : JPMorgan Chase mantiene la raccomandazione Buy	ZM

SPRINGWORKS THERAPEUTICS, INC. : JPMorgan Chase mantiene la raccomandazione Buy	07/03	ZM
SPRINGWORKS THERAPEUTICS, INC. : HC Wainwright mantiene la raccomandazione Buy	06/03	ZM
SPRINGWORKS THERAPEUTICS, INC. : Wedbush mantiene la raccomandazione Buy	26/02	ZM
SPRINGWORKS THERAPEUTICS, INC. : giudizio positivo da Wedbush	07/02	ZM
SPRINGWORKS THERAPEUTICS, INC. : Barclays è per il Buy	25/01	ZM
SPRINGWORKS THERAPEUTICS, INC. : prospettiva positiva di Goldman Sachs	29/11	ZM
SPRINGWORKS THERAPEUTICS, INC. : HC Wainwright ancora positivo	29/11	ZM
SPRINGWORKS THERAPEUTICS, INC. : HC Wainwright rimane Buy	28/11	ZM
SPRINGWORKS THERAPEUTICS, INC. : giudizio positivo da HC Wainwright	20/11	ZM
SPRINGWORKS THERAPEUTICS, INC. : HC Wainwright rimane Buy	09/11	ZM
SPRINGWORKS THERAPEUTICS, INC. : prospettiva positiva di HC Wainwright	07/08/23	ZM
SPRINGWORKS THERAPEUTICS, INC. : Goldman Sachs conferma il rating Buy	20/07/23	ZM
SPRINGWORKS THERAPEUTICS, INC. : Barclays ottimista sul caso	28/04/23	ZM
SPRINGWORKS THERAPEUTICS, INC. : JPMorgan Chase ribadisce il giudizio positivo sul titolo	07/03/23	ZM
SPRINGWORKS THERAPEUTICS, INC. : prospettiva positiva di HC Wainwright	07/03/23	ZM
SPRINGWORKS THERAPEUTICS, INC. : Goldman Sachs rimane Buy	26/01/23	ZM
SPRINGWORKS THERAPEUTICS, INC. : giudizio positivo di BofA Securities	01/12/22	ZM
SPRINGWORKS THERAPEUTICS, INC. : da Wedbush è Buy	23/11/22	ZM
SPRINGWORKS THERAPEUTICS, INC. : HC Wainwright ottimista sul caso	04/11/22	ZM
SPRINGWORKS THERAPEUTICS, INC. : Goldman Sachs ottimista sul caso	03/11/22	ZM

Non ci sono risultati per questa ricerca